Published date: 24 July 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£765,000,000
Procurement reference
CF-2393800D0O000000rwimUAA
Published date
24 July 2024
Closing date
21 March 2024
Closing time
1pm
Contract start date
1 July 2024
Contract end date
30 April 2027
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024
Offer reference number: CM/PHS/22/5661
Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
More information
Previous notice about this procurement
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
- Awarded contract
- Published 11 June 2024
Attachments
-
- 03 Framework Agreement and Terms and Conditions - CM-PHS-22-5661.docx
- 03 Framework Agreement and Terms and Conditions - CM-PHS-22-5661
-
- 2024 S 000-016397 - F14_ Corrigendum Notice for changes or additional information.pdf
- 2024 S 000-016397 - F14_ Corrigendum Notice for changes or additional information
-
- FTS - 005350-2024 - OPPORTUNITY NOTICE Blood Disorders including Haemophilia A and B - July 2024.pdf
- FTS - 005350-2024 - OPPORTUNITY NOTICE Blood Disorders including Haemophilia A and B - July 2024
-
- Document No. 09 - Participating Authorities CM-PHS-22-5661.xlsx
- Document No. 09 - Participating Authorities CM-PHS-22-5661
-
- Transparency Award Schedules - CM-PHS-22-5661.pdf
- Transparency Award Schedules - CM-PHS-22-5661
-
- Parties appointed to the framework agreement - CM-PHS-22-5661.docx
- Parties appointed to the framework agreement - CM-PHS-22-5661
Award information
Awarded date
31 May 2024
Contract start date
1 July 2024
Contract end date
30 April 2027
Total value of contract
£765,000,000
This contract was awarded to 9 suppliers.
Pfizer Ltd
Address
Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth,, Surrey,, KT20 7NS
Reference
None
Supplier is SME?
No
Roche Products Ltd
Address
Hexagon Place, Falcon Way, Shire Park,, Welwyn Garden City, AL7 1TW
Reference
None
Supplier is SME?
No
Novo Nordisk
Address
3 City Place. Beehive Ring Road., Gatwick. West Sussex, RH6 0PA
Reference
None
Supplier is SME?
No
Sobi (Swedish Orphan Biovitrum Ltd)
Address
Swedish Orphan Biovitrum Ltd, Suite 2, Riverside 3, Great Abington,, Cambridgeshire., CB21 6AD
Reference
None
Supplier is SME?
Yes
Takeda UK Ltd
Address
1 Kingdom Street,, London, W2 6BD
Reference
None
Supplier is SME?
No
LFB
Address
LFB Biopharmaceuticals Limited, Suite 104, Spirella Building, Bridge Road, Letchworth Garden City,, Hertfordshire,, SG6 4ET.
Reference
None
Supplier is SME?
No
Bio Products Laboratory Ltd
Address
Dagger Lane,, Elstree, Hertfordshire, WD6 3BX
Reference
None
Supplier is SME?
No
Octapharma Limited
Address
Glassworks House, 32 Shudehill,, Manchester,, M4 1EZ
Reference
None
Supplier is SME?
No
CSL Behring UK Ltd
Address
4 Milton Road Haywards Heath, West Sussex, RH16 1AH
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Katie Noonan
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
GB
Share this notice
Closing: 21 March 2024, 1pm